138 related articles for article (PubMed ID: 29755535)
41. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study.
Praveen A; Aqil M; Imam SS; Ahad A; Moolakkadath T; Ahmad FJ
Colloids Surf B Biointerfaces; 2019 Feb; 174():553-562. PubMed ID: 30502666
[TBL] [Abstract][Full Text] [Related]
42. Easy preparation of a liposome-mediated protein delivery system by freeze-thawing a liposome-protein complex.
Koide H; Ochiai H; Suzuki H; Hirata S; Watanabe M; Yonezawa S; Dewa T; Oku N; Asai T
J Mater Chem B; 2022 Sep; 10(35):6768-6776. PubMed ID: 35506943
[TBL] [Abstract][Full Text] [Related]
43. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system.
Jeon SO; Hwang HJ; Oh DH; Seo JE; Chun KH; Hong SM; Kim MJ; Kim WC; Park MS; Yoon CH; Min KH; Suh CW; Lee S
J Microencapsul; 2012; 29(3):234-41. PubMed ID: 22214321
[TBL] [Abstract][Full Text] [Related]
44. RSM and ANN modeling-based optimization approach for the development of ultrasound-assisted liposome encapsulation of piceid.
Huang SM; Kuo CH; Chen CA; Liu YC; Shieh CJ
Ultrason Sonochem; 2017 May; 36():112-122. PubMed ID: 28069190
[TBL] [Abstract][Full Text] [Related]
45. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
46. Encapsulation of enrofloxacin in liposomes I: preparation and in vitro characterization of LUV.
Sezer AD; Baş AL; Akbuğa J
J Liposome Res; 2004; 14(1-2):77-86. PubMed ID: 15461934
[TBL] [Abstract][Full Text] [Related]
47. Effect of Cholesterol on Nano-Structural Alteration of Light-Activatable Liposomes via Laser Irradiation: Small Angle Neutron Scattering Study.
Yuan Z; Das S; Do C; Park YC
Colloids Surf A Physicochem Eng Asp; 2022 May; 641():. PubMed ID: 35295084
[TBL] [Abstract][Full Text] [Related]
48. Transferrin targeted liposomal 5-fluorouracil induced apoptosis via mitochondria signaling pathway in cancer cells.
Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Dorkoosh FA; Handali S
Life Sci; 2018 Feb; 194():104-110. PubMed ID: 29275107
[TBL] [Abstract][Full Text] [Related]
49. Preparation, characterization, cytotoxicity and drug release behavior of liposome-enveloped paclitaxel/Fe3O4 nanoparticles.
Kim MJ; Jang DH; Lee YI; Jung HS; Lee HJ; Choa YH
J Nanosci Nanotechnol; 2011 Jan; 11(1):889-93. PubMed ID: 21446568
[TBL] [Abstract][Full Text] [Related]
50. Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system.
Thakkar HP; Baser AK; Parmar MP; Patel KH; Ramachandra Murthy R
J Liposome Res; 2012 Jun; 22(2):139-47. PubMed ID: 22149643
[TBL] [Abstract][Full Text] [Related]
51. Comparative physicochemical characterization and bioavailability of nano-liposomes formed by mixing lipids at different ratios.
Oh Y; Wi R; Choi YB; Kim DH; Chae C
J Nanosci Nanotechnol; 2012 Jul; 12(7):6131-8. PubMed ID: 22966721
[TBL] [Abstract][Full Text] [Related]
52. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
Haghiralsadat F; Amoabediny G; Sheikhha MH; Zandieh-Doulabi B; Naderinezhad S; Helder MN; Forouzanfar T
Chem Biol Drug Des; 2017 Sep; 90(3):368-379. PubMed ID: 28120466
[TBL] [Abstract][Full Text] [Related]
53. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
[TBL] [Abstract][Full Text] [Related]
54. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
55. Development of nobiliside A loaded liposomal formulation using response surface methodology.
Xiong Y; Guo D; Wang L; Zheng X; Zhang Y; Chen J
Int J Pharm; 2009 Apr; 371(1-2):197-203. PubMed ID: 19162146
[TBL] [Abstract][Full Text] [Related]
56. Ultrasound-Sensitive Liposomes for Triggered Macromolecular Drug Delivery: Formulation and
de Matos MBC; Deckers R; van Elburg B; Lajoinie G; de Miranda BS; Versluis M; Schiffelers R; Kok RJ
Front Pharmacol; 2019; 10():1463. PubMed ID: 31866867
[TBL] [Abstract][Full Text] [Related]
57. Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme.
Budai M; Chapela P; Gróf P; Zimmer A; Wales ME; Wild JR; Klebovich I; Petrikovics I; Szilasi M
J Liposome Res; 2009; 19(2):163-8. PubMed ID: 19235545
[TBL] [Abstract][Full Text] [Related]
58. Thioether Phosphatidylcholine Liposomes: A Novel ROS-Responsive Platform for Drug Delivery.
Du Y; He W; Xia Q; Zhou W; Yao C; Li X
ACS Appl Mater Interfaces; 2019 Oct; 11(41):37411-37420. PubMed ID: 31556583
[TBL] [Abstract][Full Text] [Related]
59. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.
Wang X; Guan Q; Chen W; Hu X; Li L
Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217
[TBL] [Abstract][Full Text] [Related]
60. [Assemble of magnetic nanoparticles into the structure of cisplatin liposome].
Wang L; Yang CQ; Wang J
Yao Xue Xue Bao; 2011 May; 46(5):592-8. PubMed ID: 21800550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
